Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-24-000689
Filing Date
2024-11-14
Accepted
2024-11-14 15:58:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 scph13ga1.htm SC 13G/A 28503
  Complete submission text file 0000935836-24-000689.txt   29817
Mailing Address 467 CENTRAL PARK WEST NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G/A

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 241461301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)